Mr Stevens’s professional background includes leadership positions at architectural and engineering design firm, HNTB Company and Fidelity Investments. Additional leadership roles held within the medical industry feature corporations
This open-label, sequential dose escalation study will be conducted at cancer institutions in Europe and will evaluate AV-951 in combination with the Folfox6 chemotherapy regimen in patients with
The terms of the deal call for payment of a non-refundable, up-front licensing fee and further payment of an additional non-refundable license fee upon procurement of the requisite
The Phase III chronic lymphocytic leukemia (CLL) front line chlorambucil combination study is an open-label, parallel-arm study that will include 444 patients with previously untreated CLL. Patients in
The Asia-Pacific Innovation Center is now the home base for new Hill-Rom teams focused on R&D projects for global applications of various Hill-Rom products. The Singapore Center is
Mr Savas serves as chairman and CEO of Alseres Pharmaceuticals. He holds a bachelor of arts degree in chemistry from Syracuse University. Mr Lunden is a principal with
Naturally present in human breast milk, DHA (docosahexaenoic acid), and ARA (arachidonic acid) are fatty acids important to infant development and growth. Clinical studies have demonstrated numerous benefits
Dr Mullis is currently a distinguished researcher at Children’s Hospital and Research Institute in Oakland, California. Dr Mullis has received a Nobel Prize in chemistry in 1993 for
Net proceeds are expected to be up to approximately $4.1 million after offering-related fees and expenses. Columbia intends to use the net proceeds from the offering for general
Research will continue via funding from the US government but operations in Proteome Systems’s (PXL) Boston office will be closed within the next three months. PXL will retain
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.